Advancing Gene and Cell Therapies for Cancer
During this conference, experts in the field will share their insights on targeting cancer-specific antigens, highlight rational combinations to further enhance the function of CAR engineered cells, describe ground-breaking efforts to engineer CAR engineered cells directly in vivo, and illuminate the biology and risks of viral vector integration.
2024 STAT Summit
By gathering real operators from the trenches who have not previously spoken out, not just talking heads, this event covers some of the biggest challenges faced by those who want to move advances out of the lab and into the world. They will discuss everything from drug development and technology invention to dealing with regulators, courting investors, and pricing and selling products.
World Orphan Drug Congress Europe
The World Orphan Drug Congress is the largest and most established orphan drugs & rare diseases meeting of its kind across the globe.
6th Annual Gene Therapy Analytical Development & CMC Summit
The 6th Gene Therapy Analytical Development & CMC Summit will unite 250+ analytical development, CMC, QC, and process development experts to showcase innovative analytical and process development methods, assess their readiness, and ultimately guarantee safety, quality, efficacy, and consistency of gene therapies to regulators.
Breakthroughs in Muscular Dystrophy
Join ASGCT and the Muscular Dystrophy Association in downtown Chicago for an unparalleled opportunity to delve into the latest advancements in research on gene and cell therapies for muscular dystrophy.
FDA Scientific Exchange 2024: Advancing Gene Editing Platforms for Rare Diseases
This Scientific Exchange with the FDA seeks to make progress on therapeutic development for rare conditions that are scientifically feasible but commercially non-viable.
Real-World Evidence Webinar Series: Integrating Randomized Controlled Trials for Drug and Biological Products Into Routine Clinical Practice
The Reagan-Udall Foundation for the FDA, in collaboration with the Food and Drug Administration (FDA), is hosting a public webinar as part of a series of webinars for FDA-issued guidance related to real-world evidence (RWE). This latest session in the webinar series will discuss the draft guidance: Integrating Randomized Controlled Trials for Drug and Biological Products Into Routine Clinical Practice.
Class Considerations on Immunogenicity for AAV Gene Therapy Products: Assessing Current Practice and New Data
This free, public event will explore key immunology-related topics that have implications across the class of AAV gene therapies, including immune responses, antibody testing, and redosing strategies.
WCBP Symposium
Stay tuned for more details
The Festival of Genomics & Biodata London
With well over 5,000 attendees the Festival is now the [...]
Advanced Therapies 2025
The Advanced Therapies Congress is Europe’s largest commerical cell and [...]
8th Gene Therapy Development Summit
Join peers to drive gene therapy innovation across translational, clinical, regulatory, and manufacturing tracks.
CRISPR MEDiCiNE 2025
Meet the global CRISPR Medicine community at the second CRISPR MEDiCiNE conference.
2nd International Conference on Human Genetics and Genetical Disorders
Human Genetics and Genetical Disorders-2025 extend our immense pleasure and honor [...]
ASGCT 2025
Stay tuned for more information on ASGCT's 2025 annual meeting. [...]
The Festival of Genomics & Biodata
The Festival is designed principally for scientists and clinicians who are [...]
Cell & Gene Therapy Summit 2025
We cordially invite you to The Global Cell & Gene [...]